Delays in the Definitive Treatment of Uveal Melanoma Can Increase Metastatic Disease
March 4, 2025: Recent studies suggest that delays in the definitive treatment of uveal melanoma may increase the risk of metastatic disease. This topic has been the subject of considerable debate.
In this study, Drs. Paul T. Finger, Gustav Stålhammar and Salvatore Grisanti combine and contrast medical evidence from several recent publications seeking to clarify the association between treatment delays and prognosis. The increased risk of metastasis in patients with local tumor recurrence further highlights the importance of timely treatment. Additionally, new data on circulating tumor cells and treatment timing challenge the traditional practice of observing small melanomas.
In this study, Drs. Paul T. Finger, Gustav Stålhammar and Salvatore Grisanti combine and contrast medical evidence from several recent publications seeking to clarify the association between treatment delays and prognosis. The increased risk of metastasis in patients with local tumor recurrence further highlights the importance of timely treatment. Additionally, new data on circulating tumor cells and treatment timing challenge the traditional practice of observing small melanomas.
|
Read the full article here: https://pubmed.ncbi.nlm.nih.gov/39594789/ or download it for free use here: Delays in the Definitive Treatment of Uveal Melanoma Can Increase Metastatic Disease |
|
Excerpt from the article
|
|
